Promoting our products places on us an ethical responsibility to provide accurate, balanced and updated information about our products to healthcare professionals, patients and consumers. These fundamental principles guide our marketing practices and interactions with healthcare professionals and customers:
Promotional practices must accurately reflect the benefits and risks of a medicine. They must be ethical.
Any information we provide must consider the needs of customers. Product information must be consistent with the product label approved by local authorities.
Sponsorships of medical or scientific events must be clearly disclosed, and the event’s purpose must be sharing relevant medical or scientific information.
Use of healthcare professionals as promotional speakers is increasingly being restricted to specific situations - for example, when a new product becomes available. Payments and other transfers of value to healthcare professionals are recorded and disclosed when required by local laws or regulations.
Hospitality must be appropriate, modest, consistent with local practices and secondary to the main purpose of any meeting.
We do not provide promotional aids or gifts to healthcare professionals, except for some small courtesy gifts. We do still provide items of medical utility.
We prohibit any personal incentives to prescribe products.
Samples may only be provided to enhance patient care. This must adhere to all local requirements.
All interactions and activities must comply with applicable local laws and regulations.
Our standards are represented within each Novartis division through Professional Practices Policies. For example, the Novartis Pharma Principles and Practices for Professionals (NP4) governs how associates in our largest division conduct business and interact with customers, including promoting medicines to healthcare professionals. The Alcon and Sandoz divisions have similar policies, and the Novartis Group Audit team works to ensure compliance.